Genmab — Januar 2018
-
I safety studiet af Tisotumab vedotin, står der december 2018 for extimated study completion. Hvornår ved vi så noget om safety og effekt, tror I
? https://clinicaltrials.gov/ct2/show/NCT02001623 -
i think if you download the last R&D presentation here, there was a section on TV, with a comparison on ORR for cervical cancer versus other treatments
http://ir.genmab.com/events.cfm#tab2 -
Godmorgen

-
Mærkeligt - Når jeg overfører fra Nordea og til No
rdnet, så er de der altid senere samme dag, senest morgenen efter. -
Jeg er også noget træt af Nordnet pt. Med trælse skift mellem "gammel" Nordnet og "ny".
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind